Tissue factor in cancer progression and angiogenesis

Thrombosis Research

Volumn 125, Issue , 2010, Pages S36-S38

  Ruf, Wolfram ^a   Yokota, Naho ^a   Schaffner, Florence ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Factor VIIa; Protease activated receptor; Thrombin; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 7A; INTEGRIN; PROTEINASE ACTIVATED RECEPTOR 2; THROMBOPLASTIN;

ANIMAL; ARTICLE; BLOOD; BLOOD CLOTTING; BREAST TUMOR; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); SIGNAL TRANSDUCTION;

ANIMALS; BLOOD COAGULATION; BREAST NEOPLASMS; FACTOR VIIA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRINS; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, PAR-2; SIGNAL TRANSDUCTION; THROMBOPLASTIN;

EID: 77955502883     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(10)70010-4     Document Type: Article

References (36)

1. Ten Cate, H, Falanga, A, Overview of the postulated mechanisms linking cancer and thrombosis. Pathophysiol Haemost Thromb 36 (2007), 122–130.
2. Amin, C, Mackman, N, Key, NS, Microparticles and cancer. Pathophysiol Haemost Thromb 36 (2008), 177–183.
3. Yokota, N, Koizume, S, Miyagi, E, Hirahara, F, Nakamura, Y, Kikuchi, K, et al. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. Br J Cancer, 2009 in press.
4. Conn, EM, Madsen, MA, Cravatt, BF, Ruf, W, Deryugina, EI, Quigley, JP, Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation. J Biol Chem 283 (2008 Jul 24), 26518–26527.
5. Ruf, W, Mueller, BM, Thrombin generation and the pathogenesis of cancer. Semin Thromb Hemost 32:Suppl 1 (2006 Apr), 61–68.
6. Schaffner, F, Ruf, W, Tissue factor and PAR2 signaling in the tumor microenvironment. Arterioscler Thromb Vasc Biol 29 (2009), 1999–2004.
7. Yu, J, May, L, Milsom, C, Anderson, GM, Weitz, JI, Luyendyk, JP, et al. Contribution of host-derived tissue factor to tumor neovascularization. Arterioscler Thromb Vasc Biol 28 (2008 Nov), 1975–1981.
8. Milsom, C, Rak, J, Tissue factor and cancer. Pathophysiol Haemost Thromb 36 (2007), 160–176.
9. Chand, HS, Ness, SA, Kisiel, W, Identification of a novel human tissue factor splice variant that is upregulated in tumor cells. Int J Cancer 118 (2006 Apr 1), 1713–1720.
10. Signaevsky, M, Hobbs, J, Doll, J, Liu, N, Soff, GA, Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis. Semin Thromb Hemost 34 (2008 Mar), 161–169.
11. Dorfleutner, A, Hintermann, E, Tarui, T, Takada, Y, Ruf, W, Crosstalk of integrin a3b1 and tissue factor in cell migration. Mol Biol Cell 15 (2004), 4416–4425.
12. van den Berg, YW, van den Hengel, LG, Myers, HR, Ayachi, O, Jordanova, E, Ruf, W, et al. Alternatively spliced tissue factor induces angiogenesis through integrin ligation. Proc Natl Acad SciUSA 106 (2009 Nov 17), 19497–19502.
13. Ruf, W, Tissue factor and PAR signaling in tumor progression. Thromb Res 120:Suppl 2 (2007), S7–S12.
14. Versteeg, HH, Schaffner, F, Kerver, M, Petersen, HH, Ahamed, J, Felding-Habermann, B, et al. Inhibition of tissue factor signaling suppresses tumor growth. Blood 111 (2008), 190–199.
15. Koizume, S, Jin, M-S, Miyagi, E, Hirahara, F, Nakamura, Y, Piao, J-H, et al. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. Cancer Res 66 (2006 Oct 16), 9453–9460.
16. Koizume, S, Yokota, N, Miyagi, E, Hirahara, F, Nakamura, Y, Sakuma, Y, et al. HNF-4-independent synthesis of coagulation factor VII in breast cancer cells and its inhibition by targeting selective histone acetyltransferases. Mol Cancer Res, 2009 in press.
17. Liu, Y, Mueller, BM, Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways. Biochem Biophys Res Commun 344 (2006 Jun 16), 1263–1270.
18. Albrektsen, T, Sorensen, BB, Hjortoe, GM, Fleckner, J, Rao, LVM, Petersen, LC, Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells. J Thromb Haemost 5 (2007), 1588–1597.
19. DeFea, KA, Zalevsky, J, Thoma, MS, Déry, O, Mullins, RD, Bunnett, N, b-Arrestin-dependent endocyrosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148 (2000), 1267–1281.
20. Kumar, P, Lau, CS, Mathur, M, Wang, P, DeFea, KA, Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2. Am J Physiol Cell Physiol 293 (2007 Jul), C346–C357.
21. Ge, L, Ly, Y, Hollenberg, M, DeFea, K, A b-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2 induced chemotaxis. J Biol Chem 278 (2003 Jun 23), 34418–34426.
22. Ge, L, Shenoy, SK, Lefkowitz, RJ, DeFea, K, Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. J Biol Chem 279 (2004 Dec 31), 55419–55424.
23. Zoudilova, M, Kumar, P, Ge, L, Wang, P, Bokoch, GM, DeFea, KA, Beta -arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2. J Biol Chem 282 (2007 May 11), 20634–20646.
24. Shi, X, Gangadharan, B, Brass, LF, Ruf, W, Mueller, BM, Protease-activated receptor 1 (PAR1) and PAR2 contribute to tumor cell motility and metastasis. Mol Cancer Res 2 (2004), 395–402.
25. Ahamed, J, Versteeg, HH, Kerver, M, Chen, VM, Mueller, BM, Hogg, PJ, et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci USA 103 (2006), 13932–13937.
26. Versteeg, HH, Schaffner, F, Kerver, M, Ellies, LG, Andrade-Gordon, P, Mueller, BM, et al. Protease activated receptor (PAR)2, but not PAR1 signaling promotes the development of mammary adenocarcinoma in PyMT mice. Cancer Res 68 (2008), 7219–7227.
27. Even-Ram, S, Uziely, B, Cohen, P, Grisaru-Granovsky, S, Maoz, M, Ginzburg, Y, et al. Thrombin receptor overexpression in malignant and physiological invasion processes. Nature Med 4 (1998), 909–914.
28. Abe, K, Shoji, M, Chen, J, Bierhaus, A, Danave, I, Micko, C, et al. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci USA 96 (1999), 8663–8668.
29. Ahamed, J, Ruf, W, Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain. J Biol Chem 279 (2004), 23038–23044.
30. Belting, M, Ahamed, J, Ruf, W, Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and Cancer. Arterioscler Thromb Vasc Biol 25 (2005 May 19), 1545–1550.
31. Ryden, L, Grabau, D, Schaffner, F, Jonsson, PE, Ruf, W, Belting, M, Evidence for tissue factor phosphorylation and its correlation with protease activated receptor expression and the prognosis of primary breast cancer. Int J Cancer, 2009 in press.
32. Hembrough, TA, Swartz, GM, Papathanassiu, A, Vlasuk, GP, Rote, WE, Green, SJ, et al. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res 63 (2003 Jun 1), 2997–3000.
33. Zhao, J, Aguilar, G, Palencia, S, Newton, E, Abo, A, rNAPc2 inhibits colorectal cancer in mice through tissue factor. Clin Cancer Res 15 (2009 Jan 1), 208–216.
34. Pawlinski, R, Fernandes, A, Kehrle, B, Pedersen, B, Parry, G, Erlich, J, et al. Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. Proc Natl Acad Sci USA 99 (2002 Nov 26), 15333–15338.
35. Snyder, LA, Rudnick, KA, Tawadros, R, Volk, A, Tam, SH, Anderson, GM, et al. Expression of human tissue factor under the control of the mouse tissue factor promoter mediates normal hemostasis in knock-in mice. J Thromb Haemost 6 (2008 Feb), 306–314.
36. Kelso, EB, Lockhart, JC, Hembrough, T, Dunning, L, Plevin, R, Hollenberg, MD, et al. Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation. J Pharmacol Exp Ther 316 (2006 Mar), 1017–1024.